A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Kineta Inc.
Institut Bergonié
Blue Note Therapeutics
Institut National de la Santé Et de la Recherche Médicale, France
National Cancer Center, Korea
Tel-Aviv Sourasky Medical Center